LitCovid-sample-Enju  

PMC:7199903 / 15611-15870 JSONTXT 11 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T49489 0-2 IN denotes As
T30681 3-5 DT denotes an
T53669 6-16 VBG denotes increasing
T65899 17-23 NN denotes number
T82409 24-26 IN denotes of
T8477 27-45 JJ denotes glycoprotein-based
T94196 46-53 NN denotes vaccine
T43282 54-64 NNS denotes candidates
T96948 65-68 VBP denotes are
T96900 69-74 VBG denotes being
T67675 75-84 VBN denotes developed
T62659 84-85 -COMMA- denotes ,
T20755 86-91 PRP-DOLLAR- denotes their
T47361 92-100 JJ denotes detailed
T51541 101-107 NN denotes glycan
T66124 108-116 NN denotes analysis
T40599 117-123 VBZ denotes offers
T90463 124-125 DT denotes a
T34862 126-131 NN denotes route
T97151 132-135 IN denotes for
T93438 136-145 VBG denotes comparing
T16844 146-155 NN denotes immunogen
T61238 156-165 NN denotes integrity
T30860 166-169 CC denotes and
T24785 170-174 MD denotes will
T90065 175-179 RB denotes also
T99893 180-182 VB denotes be
T50945 183-192 JJ denotes important
T69841 193-195 TO denotes to
T90334 196-203 VB denotes monitor
T29169 204-206 IN denotes as
T25038 207-220 NN denotes manufacturing
T2806 221-230 NNS denotes processes
T74292 231-234 VBP denotes are
T70120 235-241 VBN denotes scaled
T94082 242-245 IN denotes for
T25098 246-254 JJ denotes clinical
T10017 255-258 NN denotes use
R10200 T99893 T30860 arg2Of be,and
R10910 T65899 T96900 arg1Of number,being
R11044 T90334 T69841 arg1Of monitor,to
R16897 T65899 T96948 arg1Of number,are
R20765 T30860 T49489 arg1Of and,As
R21041 T30860 T62659 arg1Of and,","
R22057 T90334 T29169 arg1Of monitor,as
R2384 T61238 T16844 arg1Of integrity,immunogen
R24529 T70120 T74292 arg2Of scaled,are
R24618 T70120 T29169 arg2Of scaled,as
R27591 T66124 T51541 arg1Of analysis,glycan
R28753 T34862 T97151 arg1Of route,for
R30149 T2806 T74292 arg1Of processes,are
R30814 T50945 T99893 arg2Of important,be
R35041 T70120 T94082 arg1Of scaled,for
R36722 T43282 T82409 arg2Of candidates,of
R37520 T66124 T40599 arg1Of analysis,offers
R40051 T99893 T90065 arg1Of be,also
R40732 T40599 T30860 arg1Of offers,and
R52389 T10017 T25098 arg1Of use,clinical
R58029 T67675 T49489 arg2Of developed,As
R58845 T2806 T25038 arg1Of processes,manufacturing
R59298 T99893 T24785 arg2Of be,will
R66613 T43282 T94196 arg1Of candidates,vaccine
R67093 T66124 T50945 arg1Of analysis,important
R72543 T66124 T20755 arg1Of analysis,their
R74524 T66124 T24785 arg1Of analysis,will
R75058 T99893 T69841 modOf be,to
R77292 T93438 T97151 arg2Of comparing,for
R77975 T34862 T90463 arg1Of route,a
R82168 T67675 T96948 arg2Of developed,are
R83780 T2806 T70120 arg2Of processes,scaled
R86101 T43282 T8477 arg1Of candidates,glycoprotein-based
R86760 T65899 T67675 arg2Of number,developed
R92826 T67675 T96900 arg2Of developed,being
R93288 T65899 T30681 arg1Of number,an
R93896 T34862 T40599 arg2Of route,offers
R93934 T66124 T99893 arg1Of analysis,be
R95637 T66124 T47361 arg1Of analysis,detailed
R95930 T65899 T82409 arg1Of number,of
R96396 T65899 T53669 arg1Of number,increasing
R96457 T61238 T93438 arg2Of integrity,comparing
R98113 T10017 T94082 arg2Of use,for